CERA: Revenue surged 27.4%; margin recovery is expected as pricing actions take hold

What happened

Cera Sanitaryware reported Q2 FY27 revenue of ₹603 crore, up 27.4% year over year. Its EBITDA margin, the share of revenue left after operating costs, was 12.2%, down amid higher input costs but improved from the prior quarter. The company kept its FY27 growth and margin outlooks unchanged.

Confirmed

Global impact / market context

Revenue growth indicates stronger sales, but higher input costs reduced the share of revenue left after operating costs. If pricing actions take hold as the headline expects, they could help restore that share; if costs remain elevated or price increases slow sales, the recovery may be weaker.

Analyst inference

The supplied figures show sales growing faster than the company’s full-year growth outlook, while the quarterly operating-cost measure remains below its full-year margin outlook. That contrast makes the balance between pricing, input costs, and customer demand important to future earnings, without establishing how investors have responded.

Analyst inference

What to watch

1. Check whether subsequent results show pricing actions taking hold through a higher EBITDA margin, and whether that improvement occurs alongside continued revenue growth. Analyst inference
2. Compare full-year revenue growth with the stated 18–20% outlook and EBITDA margin with the 13–14% outlook as results are reported. Confirmed
3. Watch for updates on input costs and pricing; persistent cost pressure or weaker demand after price increases could limit profit recovery. Analyst inference

Evidence

• Original source link unavailable